Authors

• A Meisel
• Sarah Hoffmann (ORCID: https://orcid.org/0000-0001-9549-2594)
• Meret Herdick (ORCID: https://orcid.org/0000-0003-0119-9499)
• Pushpa Narayanaswami (ORCID: https://orcid.org/0000-0002-9412-7349)
• Frauke Stascheit (ORCID: https://orcid.org/0000-0001-5306-7880)
• Philipp Mergenthaler (ORCID: https://orcid.org/0000-0002-9753-6711)
• Sophie Lehnerer (ORCID: https://orcid.org/0000-0001-9007-027X)
• Maike Stein (ORCID: https://orcid.org/0009-0002-1514-8385)
• Paolo Doksani (ORCID: https://orcid.org/0009-0009-5381-5995)
• Haoqi Sun
• Maximilian Mönch (ORCID: https://orcid.org/0009-0006-6267-5400)
• Carla Dusemund (ORCID: https://orcid.org/0000-0001-6477-8901)
• Lea Gerischer
• Hannah Preßler

Institutions

• Beth Israel Deaconess Medical Center (US)
• Harvard University (US)
• Humboldt-Universität zu Berlin (DE)
• University of Oxford (GB)
• Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
• Charité - Universitätsmedizin Berlin (DE)

Publication Details

Journal

Annals of Clinical and Translational Neurology

Published

2025-12-21

DOI

https://doi.org/10.1002/acn3.70293

Primary Topic

Myasthenia Gravis and Thymoma

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Argenx
• Deutsche Forschungsgemeinschaft